EURORDIS: Patient survey on adverse drug reactions27.09.2016
EMSP is supporting a survey intiative from our partners at Rare Diseases Europe (EURORDIS) aimed at reporting side-effects and receiving safety information on medicines through an app for mobile phones and tablets.
The Web-RADAR survey: Recognising Adverse Drug reactions is available in seven European languages and takes about 15 minutes to complete:
- General link: https://www.unipark.de/uc/WEB-RADR/PT/
- German: https://www.unipark.de/uc/PT/DE/
- English: https://www.unipark.de/uc/PT/EN/
- Spanish: https://www.unipark.de/uc/PT/ES/
- French: https://www.unipark.de/uc/PT/FR/
- Croatian: https://www.unipark.de/uc/PT/HR/
- Dutch: https://www.unipark.de/uc/PT/NL/
- Portuguese: https://www.unipark.de/uc/PT/PT/
Find more information here.
Unreported adverse drug reactions
The European Medicines Agency (EMA) recently acknowledged that 96 percent of adverse drug reactions (ADRs) currently go unreported:
— Claudiu Berbece (@ClaudiuBerbece) September 19, 2016